← All stocks

Arxis, Inc.

ARXS No buying or selling

CIK 0002093536 #680 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

9 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Perhamus Kevin Scott

See Remarks

—

3,573,133

0.889%

$100.05M

—

Sealfon Ross Bradley

See Remarks

—

1,102,807

0.274%

$30.88M

—

Roth Jason Aaron

See Remarks

—

429,613

0.107%

$12.03M

—

Badakhsh Azad Sid

See Remarks

—

403,864

0.101%

$11.31M

—

Jankowski Ryan Anthony

Chief Accounting Officer

—

59,848

0.015%

$1.68M

—

Allen Jennifer H.

See Remarks

—

53,695

0.013%

$1.50M

—

Oetgen Stephen Duane

Director

—

30,357

0.008%

$850.00K

—

ALLEN PATRICK E

Director

—

15,357

0.004%

$430.00K

—

Arcline Double Eagle Master Fund-A LP entity

Director

—

<0.001%

$28.00

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 34,098

History held since 20 Apr 2026